Capability | Core Services
Exploratory R&D and Strategy
Strategic guidance from concept to clinical impact—grounded in first-hand experience, clinical research expertise, and an unwavering commitment to patient outcomes.
How do you navigate the complex path from preclinical feasibility to global market access?
We provide end-to-end strategic support that connects proof-of-concept to regulatory approval. By anticipating evidence requirements early in the development lifecycle, we construct robust clinical evidence strategies and data-driven regulatory pathways that accelerate timelines and mitigate risk.
Specific Capabilities
Data-Driven Regulatory Strategy
Develop evidence-based regulatory pathways tailored to your target markets, device risk profile, and clinical claims.
- FDA 510(k), PMA, and De Novo pathway planning and predicate identification
- CE Mark (MDR) technical documentation and clinical evaluation reports
- Pre-Submission (Q-Sub) strategy and agency interaction support
- QMS development (ISO 13485) and risk management (ISO 14971)
Clinical Evidence Generation
Design clinical studies that properly assess benefit-risk, align with regulatory expectations, and support strong market access claims.
- First-in-Human (FIH) and Early Feasibility Study (EFS) design
- Pivotal trial endpoint selection and statistical powering strategies
- Patient-Reported Outcomes (PRO) integration
- Real-World Evidence (RWE) generation and post-market registry design
Market Access & Ecosystem Strategy
Navigate complex payer landscapes and build comprehensive value propositions that secure favorable reimbursement and drive broad clinical adoption.
- Payer coverage pathway planning (CMS, commercial, international)
- Health Economics and Outcomes Research (HEOR) modeling
- Value dossier development demonstrating cost-effectiveness
- Key Opinion Leader (KOL) engagement and advisory board facilitation
Submission-Ready Documentation
We combine profound technical expertise with uncompromising integrity to deliver actionable protocols and definitive regulatory guidance. From gap analyses to final submissions, we act as an embedded extension of your team.